Hightide Biopharma Pty Ltd

This study tested whether a new medication called HTD1801 could help adults with type 2 diabetes who weren't reaching their blood sugar goals with metformin alone. Over 550 participants took either HTD1801 or a placebo pill for 24 weeks, followed by an extension period where ever…

This study tested whether a new oral drug called HTD1801 could help control primary sclerosing cholangitis (PSC), a rare disease that scars the bile ducts in the liver. For 18 weeks, 59 adult patients took either one of two doses of HTD1801 or a placebo pill. The main goal was to…

This study tested whether a new medication called HTD1801 could help lower blood sugar in adults with type 2 diabetes that wasn't well controlled by diet and exercise alone. Over 400 participants were randomly assigned to take either HTD1801 or a placebo pill for 24 weeks, follow…

This study tested if a new drug called HTD1801 works as well as an established drug, dapagliflozin, for lowering blood sugar in people with type 2 diabetes. It involved 367 adults whose diabetes wasn't well-controlled on metformin alone. For 24 weeks, participants took either the…